In the recent past gene profiling in tumor tissues suggests that breast cancers may be divided into subtypes dependent on presence or absence of oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER 2). This evidence concerns the gene ERBB2 and breast carcinoma.